Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Boehringer Ingelheim scientists claim new antiproliferative agents

Oct. 5, 2004

Triple angiokinase inhibitor, BIBF-1120, shows promise for clinical development

Oct. 4, 2004

Studies show biological activity and tolerability of AZD-3409

Oct. 4, 2004

Preliminary clinical results reported for chimeric anti-alpha5beta1 MAb

Oct. 4, 2004

Daily oral CP-724714 well tolerated in first clinical study

Oct. 4, 2004

Selenophene derivative induces apoptosis in renal cancer cells

Oct. 4, 2004

Daily administration of A6 well tolerated in gynecological cancer patients

Oct. 4, 2004

AZD-2171 useful in combination with other antitumor agents

Oct. 4, 2004

Metvix approved in eight more European countries

Oct. 4, 2004

Cellular Genomics presents new Hsp90 modulators

Oct. 4, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 13, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026